Valuation: COMPASS Pathways plc

Market Cap 1.79B 1.57B 1.45B 1.35B 2.55B 171B 2.6B 17.43B 6.75B 83.7B 6.73B 6.59B 291B P/E 2026 *
-12.9x
P/E 2027 * -9.36x
Enterprise Value 1.37B 1.2B 1.11B 1.03B 1.94B 130B 1.98B 13.31B 5.16B 63.9B 5.14B 5.03B 222B EV / Sales 2026 *
-
EV / Sales 2027 * 21.4x
Free-Float
25.07%
Yield 2026 *
-
Yield 2027 * -
1 day-6.08%
1 week+5.64%
Current month-6.08%
1 month-6.34%
3 months+136.48%
6 months+92.61%
Current year+92.61%
1 week 13.27
Extreme 13.27
15.4
1 month 10.72
Extreme 10.724
15.4
Current year 4.88
Extreme 4.88
15.4
1 year 3.24
Extreme 3.24
15.4
3 years 2.25
Extreme 2.25
15.4
5 years 2.25
Extreme 2.25
49.52
10 years 2.25
Extreme 2.25
61.69
Manager TitleAgeSince
Chief Executive Officer 61 01/08/2022
Director of Finance/CFO 54 01/03/2024
Chief Tech/Sci/R&D Officer 66 01/05/2024
Director TitleAgeSince
Chairman 74 29/03/2024
Director/Board Member 69 01/04/2020
Director/Board Member 66 01/03/2021
Date Insider Type Main position Quantity % Market Cap.
05-27Free

Chairman

30,158 0.0314%
05-27Free

Director

21,110 0.0220%
05-27Free

Director

21,110 0.0220%
Change 5-day change 1-year change 3-year change Capi.($)
-6.08%+5.64%+320.57%+60.51% 1.79B
+0.07%+4.77%+0.72%+6.31% 48.62B
+0.12%+10.45%+408.29%+600.97% 39.86B
+5.17%+9.47%+24.96%-9.60% 33.91B
+2.02%+4.91%+18.59%+63.06% 32.32B
+0.69%+1.04%+14.23%+30.86% 24.73B
+0.40%+12.51% - - 16.63B
+2.64%+6.00%+69.30%+126.33% 15.52B
+0.18%+0.44%+13.06%+17.75% 13.63B
+0.77%+10.67%+17.58%-30.04% 13.41B
Average +0.60%+7.53%+98.59%+96.24% 24.04B
Weighted average by Cap. +1.31%+7.18%+90.14%+128.01%

Financials

2026 *2027 *
Net sales - 60.17M 52.83M 48.63M 45.32M 85.46M 5.72B 87.2M 585M 227M 2.81B 226M 221M 9.77B
Net income -100M -88.09M -81.09M -75.56M -142M -9.54B -145M -975M -378M -4.68B -377M -369M -16.3B -197M -173M -159M -148M -280M -18.74B -286M -1.92B -743M -9.2B -740M -724M -32.02B
Net Debt -424M -372M -343M -319M -602M -40.32B -615M -4.12B -1.6B -19.79B -1.59B -1.56B -68.88B -505M -444M -408M -381M -718M -48.06B -732M -4.91B -1.9B -23.59B -1.9B -1.86B -82.09B
Logo COMPASS Pathways plc
Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in treating mental health conditions focused on rapid and durable responses through the development of its investigational COMP360 psilocybin treatment. COMP360 is its psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.
Employees
156
Date Price Change Volume
01/07/26 $13.29 -6.08% 4,743,546
30/06/26 $14.15 -6.10% 3,467,572
29/06/26 $15.07 +1.69% 3,601,557
26/06/26 $14.82 +9.13% 5,486,747
25/06/26 $13.58 +7.95% 3,177,551
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
13.29USD
Average target price
22.33USD
Spread / Average Target
+68.05%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CMPS Stock